0
REGULAR ARTICLES   |    
Informed consent for neuroleptic therapy
Am J Psychiatry 1979;136:959-962.
An erratum to this article has been published | view the erratum
text A A A
PDF of the full text article.
Abstract
The author suggests that the frequency and severity of tardive dyskinesia in patients treated with neuroleptic drugs requires that informed consent be obtained from all patients receiving such treatment. The three basic conditions for obtaining informed consent are reviewed with discussion of some of the ethical problems encountered in the informed consent procedure. Most of these problems will be resolved if specific, written, informed consent is obtained from the patient, or his representative, within six weeks of initiating therapy, although in some cases questions may be raised about the very possibility of obtaining consent.Abstract Teaser
Figures in this Article

    Your Session has timed out. Please sign back in to continue.
    Sign In Your Session has timed out. Please sign back in to continue.
    Sign In to Access Full Content
     
    Username
    Password
    Sign in via Athens (What is this?)
    Athens is a service for single sign-on which enables access to all of an institution's subscriptions on- or off-site.
    Not a subscriber?

    Subscribe Now/Learn More

    PsychiatryOnline subscription options offer access to the DSM-IV-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

    Need more help? PsychiatryOnline Customer Service may be reached by emailing PsychiatryOnline@psych.org or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

    +
    +
    +

    CME Activity

    There is currently no quiz available for this resource. Please click here to go to the CME page to find another.
    Submit a Comments
    Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
    Comments are moderated and will appear on the site at the discertion of JBJS editorial staff.

    * = Required Field
    (if multiple authors, separate names by comma)
    Example: John Doe



    Related Content
    Articles
    Books
    Manual of Clinical Psychopharmacology, 7th Edition > Chapter 4.  >
    The American Psychiatric Publishing Textbook of Psychiatry, 5th Edition > Chapter 26.  >
    Gabbard's Treatments of Psychiatric Disorders, 4th Edition > Chapter 20.  >
    Dulcan's Textbook of Child and Adolescent Psychiatry > Chapter 49.  >
    What Your Patients Need to Know About Psychiatric Medications, 2nd Edition > Chapter 45.  >
    Topic Collections
    Psychiatric News
    APA Guidelines
    PubMed Articles